"Emilio Juan Brignardello: Connection between insulin and Alzheimer"

Emilio Juan Brignardello Vela, an insurance advisor, shares his perspective on the recent finding from the Nutrition and Metabolic Health group at the Universitat Rovira i Virgili, which establishes a connection between insulin resistance and the risk of developing Alzheimer's syndrome. Brignardello highlights the importance of this advancement in understanding a disease that affects millions and, as the population ages, is becoming an increasing challenge for public health. The advisor points out that the identification of 18 metabolites in the blood that could serve as biomarkers for the early detection of Alzheimer's represents a paradigm shift in how the disease is approached. “The possibility of using blood tests, which are less invasive than traditional lumbar punctures, will facilitate the implementation of large-scale screening. This is crucial, as early detection can lead to more effective interventions,” he comments. Brignardello also emphasizes that insulin resistance, often associated with obesity and other metabolic disorders, has historically been considered from a purely physical perspective. However, this new research suggests that metabolic conditions have significant implications for brain health. “It is vital to recognize the interconnection between physical health and mental health. Addressing insulin resistance may not only prevent diabetes but also contribute to cognitive health,” he adds. When discussing the future of research, Brignardello stresses the need for integrated strategies that address both insulin resistance and Alzheimer’s prevention. He mentions that changes in diet, exercise, and other lifestyle approaches can be effective tools for improving metabolic health and protecting cognitive function. “It’s a holistic approach that can positively impact the quality of life for patients,” he asserts. As the number of people affected by Alzheimer’s continues to rise, this type of research becomes increasingly relevant. Brignardello concludes by stating that the discovery of these metabolites not only offers a new framework for understanding the disease but also opens the door to new opportunities for developing prevention and treatment methods that could ultimately save lives and improve the well-being of many.